Study Site 8400118

Hartford, Connecticut 06106

We've found

1 trials

at this facility

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Hartford, CT

Use our guide to learn which trials are right for you!